Autologous Cell Therapy Market Poised $2.2 Billion by 2017 - PowerPoint PPT Presentation

About This Presentation
Title:

Autologous Cell Therapy Market Poised $2.2 Billion by 2017

Description:

market size, market share, market survey, market intelligence, market trends, market strategy, market research report, analysis, survey, market research surveys – PowerPoint PPT presentation

Number of Views:53

less

Transcript and Presenter's Notes

Title: Autologous Cell Therapy Market Poised $2.2 Billion by 2017


1
MarketsandMarkets Presents
Autologous Cell Therapy Market Poised 2.2
Billion by 2017
http//www.marketsandmarkets.com/Market-Reports/au
tologous-cell-therapy-market-837.html
2
The report Autologous Cell Therapy (ACT) Market
(2012 - 2017), would be the first global and
exclusive report on ACT market. It also gives
clear information about the complete industry,
approved products and potential market size it
also identifies driving and restraining factors
for the global ACT market with analysis of
trends, opportunities and challenges. The market
is segmented and revenue is forecasted on the
basis of major regions such as USA, Europe and
Rest of the World (ROW). Further, market is
segmented and revenues are forecasted on the
basis of potential application areas of
ACT. Browse ACT market research data
tables/figures spread through 111 slides and
in-depth TOC on Autologous Cell Therapy (ACT)
Market" http//www.marketsandmarkets.com/Market-R
eports/autologous-cell-therapy-market-837.html
http//www.marketsandmarkets.com/Market-Reports/au
tologous-cell-therapy-market-837.html
3
Autologous Stem Cell and Non-Stem Cell Based
Therapies market is currently estimated as 650
million, including products of all application
areas. This market is anticipated to reach 2.2
billion by 2017, growing at a CAGR of 21.
Several products and technologies of ACT are in
pipeline which is expected to hit the market
during the forecast period, which will result in
increased growth rate. Investment activities,
for past five years are actively held in research
and developments, attracting interests of cell
therapy industry firms, medical centers and
academic institutions. ACT potential can be
demonstrated by mergers, collaborations,
acquisitions and partnerships that happened
actively between the ACT technology developing
companies in past three years. Development of
sophisticated automation devices for cell
expansion and culture process for use in the
treatment is one of the emerging trends of ACT
market.
http//www.marketsandmarkets.com/Market-Reports/au
tologous-cell-therapy-market-837.html
4
Contact Us
Mr. RohanNorth - Dominion Plaza, 17304 Preston
Road, Suite 800, Dallas, TX 75252Tel
1-888-6006-441Email sales_at_marketsandmarkets.com
 MarketsandMarkets Bloghttp//twitter.com/market
smarkets
http//www.linkedin.com/company/marketsandmarkets
http//www.marketsandmarkets.com/Market-Reports/au
tologous-cell-therapy-market-837.html
5
About MarketsandMarkets
MarketsandMarkets is a global market research and
consulting company based in the U.S. We publish
strategically analyzed market research reports
and serve as a business intelligence partner to
Fortune 500 companies across the
world. MarketsandMarkets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotives and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at
MarketsandMarkets are inspired to help our
clients grow by providing apt business insight
with our huge market intelligence repository.
http//www.marketsandmarkets.com/Market-Reports/au
tologous-cell-therapy-market-837.html
Write a Comment
User Comments (0)
About PowerShow.com